William Grady is a Gastroenterology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1959 NE Pacific St
Seattle, WA 981950001
Telephone
206-520-5307Registry record last updated 9 Jul 2007.
Clinical trials
- ColoCare Study - Colorectal Cancer Cohort
Sponsor: University of Utah
- Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Sponsor: Case Western Reserve University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ERBE USA IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
53.8%Proton pump inhibitor53.8%Omeprazole100%Part D<11 patientsMusculoskeletal
46.2%Nonsteroidal Anti-inflammatory Drug46.2%Sulindac100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
17 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- A 4D-tunable hydrogel for the study of the impact of the tumor microenvironment on the development of colorectal cancer
University of Washington
FY2026$546,352R01CA289291 - Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome
Fred Hutchinson Cancer Center
FY2025$1,579,708U54CA274374 - Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
Fred Hutchinson Cancer Center
FY2025$1,029,753U2CCA271902
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”